However, Cheng W et al. show that the N-terminal proline-rich structural domain (p25-30) of GPC3 accounts for its interaction with IGF-II and IGF-1R, leading to the activation of the IGF-II/Erk pathway in HCC cells. The gene discussed is IGF2; the disease is hepatocellular carcinoma.